D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Healthcare | 9.92% |
| 4 | Financials | 7.86% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Capital One
COF
$127B
| $872K | ﹤0.01% |
8,478
-115,091
| -93% | -$11.1M |
|
|
BWIN
3027
Baldwin Insurance Group
BWIN
$2.77B
| $872K | ﹤0.01% |
+54,361
| New | +$867K |
|
3028
CALL
CDW
CDW
$18.2B
| $871K | ﹤0.01% |
+6,100
| New | +$807K |
|
|
HNGR
3029
DELISTED
Hanger Inc.
HNGR
| $871K | ﹤0.01% |
31,545
-29,937
| -49% | -$711K |
|
|
MNK
3030
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $871K | ﹤0.01% |
249,474
-616,523
| -71% | -$1.92M |
|
|
SINA
3031
CALL
DELISTED
Sina Corp
SINA
| $870K | ﹤0.01% |
+21,800
| New | +$836K |
|
3032
CALL
Core Laboratories
CLB
$509M
| $866K | ﹤0.01% |
+23,000
| New | +$1.03M |
|
3033
Bridgewater Bancshares
BWB
$587M
| $864K | ﹤0.01% |
62,702
+21,107
| +51% | +$268K |
|
3034
CALL
DaVita
DVA
$15.3B
| $863K | ﹤0.01% |
11,500
| – | – |
|
|
CTB
3035
PUT
DELISTED
Cooper Tire & Rubber Co.
CTB
| $863K | ﹤0.01% |
30,000
| – | – |
|
3036
PUT
Wingstop
WING
$3.74B
| $862K | ﹤0.01% |
10,000
| – | – |
|
|
CRHM
3037
DELISTED
CRH Medical Corporation
CRHM
| $861K | ﹤0.01% |
248,400
-5,600
| -2% | -$17.7K |
|
3038
Silicom
SILC
$208M
| $860K | ﹤0.01% |
25,862
-2,249
| -8% | -$72.6K |
|
|
MRSN
3039
DELISTED
Mersana Therapeutics
MRSN
| $848K | ﹤0.01% |
5,926
-3,737
| -39% | -$273K |
|
3040
Energizer
ENR
$1.51B
| $847K | ﹤0.01% |
+16,874
| New | +$776K |
|
3041
PUT
BioMarin Pharmaceuticals
BMRN
$12.1B
| $846K | ﹤0.01% |
10,000
| – | – |
|
3042
STAG Industrial
STAG
$7.81B
| $846K | ﹤0.01% |
26,803
-16,299
| -38% | -$500K |
|
3043
Ceco Environmental
CECO
$3.92B
| $845K | ﹤0.01% |
110,301
-7,743
| -7% | -$57.9K |
|
3044
Abeona Therapeutics
ABEO
$337M
| $843K | ﹤0.01% |
10,318
+4,226
| +69% | +$298K |
|
3045
CALL
NovoCure
NVCR
$1.91B
| $843K | ﹤0.01% |
+10,000
| New | +$807K |
|
|
WLL
3046
DELISTED
Whiting Petroleum Corporation
WLL
| $842K | ﹤0.01% |
1,530
+238
| +18% | +$115K |
|
3047
Powell Industries
POWL
$7.27B
| $841K | ﹤0.01% |
51,456
-4,392
| -8% | -$61.6K |
|
3048
PUT
Cleveland-Cliffs
CLF
$6.9B
| $840K | ﹤0.01% |
+100,000
| New | +$768K |
|
3049
Align Technology
ALGN
$12.4B
| $837K | ﹤0.01% |
3,000
-77,870
| -96% | -$19.4M |
|
3050
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.16B
| $836K | ﹤0.01% |
10,275
| – | – |
|
Similar funds
D.E. Shaw & Co's Q4 2019 Portfolio in Review
As of Q4 2019, D.E. Shaw & Co held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- D.E. Shaw & Co added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- D.E. Shaw & Co's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- D.E. Shaw & Co fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- D.E. Shaw & Co opened 572 new positions and closed 412 in Q4 2019.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.